Social anxiety and suicidality in youth: a systematic review and meta-analysis by Leigh, E, Chiu, K, Ballard, E

Social anxiety and suicidality in youth: a systematic review and meta-analysis by Leigh, E, Chiu, K, Ballard, E

Drug use trajectory patterns among older drug users by Tyndall B, Whalen T, Boeri M, Ballard E

Get full text

Focussing and levelling in the Auckland voices project by Meyerhoff, M, Ballard, E, Watson, C, Birchfield, A

Induction of Clinical and Endoscopic Remission of Mild to Moderately Active Ulcerative Colitis With Budesonide MMX (R) 9 mg: Analysis of Pooled Data from Two Phase 3 Studies by Sandborn, W, Travis, S, Bala, N, Danese, S, Moro, L, Ballard, E, Gautille, T, Bagin, B, Huang, M

Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study. by Sandborn, W, Travis, S, Moro, L, Jones, R, Gautille, T, Bagin, R, Huang, M, Yeung, P, Ballard, E

A validation study of microscopy versus quantitative PCR for measuring Plasmodium falciparum parasitemia. by Ballard, E, Wang, C, Hien, T, Tong, N, Marquart, L, Pava, Z, Tarning, J, O'Rourke, P, McCarthy, J

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies. by Sandborn, W, Danese, S, D'Haens, G, Moro, L, Jones, R, Bagin, R, Huang, M, David Ballard, E, Masure, J, Travis, S

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. by Travis, S, Danese, S, Kupcinskas, L, Alexeeva, O, D'Haens, G, Gibson, P, Moro, L, Jones, R, Ballard, E, Masure, J, Rossini, M, Sandborn, W

Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis. by Lichtenstein, G, Travis, S, Danese, S, D'Haens, G, Moro, L, Jones, R, Huang, M, Ballard, E, Bagin, R, Hardiman, Y, Collazo, R, Sandborn, W